CraigA.EricksonMD

Child & Adolescent Psychiatry

Professor, Cincinnati Children’s Hospital, University of Cincinnati College of Medicine

Dr. Erickson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3333 Burnet Ave
MLC 4002
Cincinnati, OH 45229
Phone+1 513-636-6553

Fax+1 513-636-4283

Indiana University School of Medicine (Indianapolis)Residency, Psychiatry, 2004 - 2007
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2003 - 2004
University of Cincinnati College of MedicineClass of 2003

Riluzole in Fragile X Syndrome Start of enrollment: 2009 Apr 01
Completed
Phase 4
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders Start of enrollment: 2010 Mar 01
Completed
Phase 3
Acamprosate in Youth With Fragile X Syndrome Start of enrollment: 2010 Aug 01
Completed
Phase 2
Study of Acamprosate in Autism Start of enrollment: 2013 Jul 02
Completed
Phase 1
Study of Acamprosate in Fragile x Syndrome Start of enrollment: 2013 Aug 27
Completed
Phase 1
INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD Start of enrollment: 2022 Jun 23
Terminated
Phase 2
Roles: Principal Investigator, Contact
Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG Start of enrollment: 2022 Oct 04
Recruiting
Not Applicable
Roles: Contact
Study of SPG601 in Adult Men With Fragile X Syndrome Start of enrollment: 2024 Jun 18
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

PubMed

18 citations
Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder--Initial Results of a Randomized, Controlled, Crossover, Pilot Study.
Logan K. Wink, Debra L. Reisinger, Paul S. Horn, Rebecca C. Shaffer, Kaela O'Brien
Journal of Autism and Developmental Disorders. 2021-04-01
46 citations
A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders
Noha F. Minshawi, Logan K. Wink, Rebecca C. Shaffer, Martin H. Plawecki, David J. Posey
Molecular Autism. 2016-01-14
31 citations
Voice of people with fragile X syndrome and their families: Reports from a survey on treatment priorities
Jayne Dixon Weber, Elizabeth K. Smith, Elizabeth Berry-Kravis, Diego Cadavid, David R Hessl
Brain Sciences. 2019-01-23

Journal Articles

Author Correction: Impaired Perceptual Learning in a Mouse Model of Fragile X Syndrome Is Mediated by Parvalbumin Neuron Dysfunction and Is Reversible
Ernest Pedapati, Craig A Erickson, Nature
Full Length Article Pharmacological Management of Behavioral Disturbances in Children and Adolescents with Autism Spectrum Disorders
Craig A. Erickson, Martine Lamy, ScienceDirect
Impaired Perceptual Learning in a Mouse Model of Fragile X Syndrome Is Mediated by Parvalbumin Neuron Dysfunction and Is Reversible
Ernest Pedapati, Craig A Erickson, Nature

Going on Trial: Serotonin Drug; Psilocybin Phase 2; Placebo Response DataApril 28th, 2023
Finding a Path Forward for Fragile X DrugsSeptember 23rd, 2021
New Guidelines to Improve Inpatient Care for Kids with AutismFebruary 10th, 2016
Join now to see all